LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
62 hedge funds and large institutions have $78.6M invested in La Jolla Pharmaceutical Company in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
65% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 31
Holders
62
Holding in Top 10
2
Calls
$304K
Puts
$268K
Top Buyers
| 1 | +$2.76M | |
| 2 | +$967K | |
| 3 | +$879K | |
| 4 |
E
Ergoteles
New York
|
+$353K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$311K |
Top Sellers
| 1 | -$4.77M | |
| 2 | -$1.52M | |
| 3 | -$1.29M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.1M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$772K |